Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

After Demolishing the U.S.-China Relationship, Trump Is Rebuilding It His Way

by Team Lumida
October 29, 2025
in Macro
Reading Time: 5 mins read
A A
0
Trump Tariffs Leave Key Questions on China Supply Chain Rules Unanswered
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

Powered by lumidawealth.com

  • U.S.-China trade negotiators reached framework agreement in Kuala Lumpur Sunday, setting stage for Trump-Xi deal Thursday in South Korea; transactional truce involves China resuming soybean purchases, delaying rare-earth controls; U.S. shelving new tariffs, rolling back 20% fentanyl levy.
  • Framework launches structured, leader-led diplomacy: Trump to visit Beijing early 2026, Xi reciprocal visit later that year—stunning reversal from first-term confrontation. Analysts say Beijing achieving “strategic stalemate” to buy time for catch-up.
  • Truce doesn’t address core issues (state subsidies, IP theft, tech dominance); concessions tactical, not structural. Both sides using pause to derisk: China pushing chip self-sufficiency, U.S. building rare-earth alternatives.
  • Xi needs time for domestic economy (persistent slowdown); Trump gets dealmaker optics and soybean wins for GOP states. Fundamental stress points (Taiwan, South China Sea, AI/quantum race) remain unresolved and volatile.

What Happened?

U.S. and Chinese trade negotiators reached a framework agreement Sunday in Kuala Lumpur after two days of tense talks, setting the stage for President Trump and Chinese leader Xi Jinping to agree on a major deal Thursday in South Korea. The transactional truce involves China resuming U.S. soybean purchases and delaying new rare-earth controls; the U.S. shelving new tariffs, rolling back the 20% fentanyl levy, and potentially refraining from new policy actions against China. The framework launches structured, leader-led diplomacy: Trump is expected to visit Beijing early 2026, followed by a reciprocal Xi visit later that year—a stunning reversal from Trump’s first-term confrontation. Analysts say Beijing is achieving a “strategic stalemate” to buy time for catch-up.

The truce doesn’t address core issues (state subsidies, IP theft, tech dominance); concessions are tactical, not structural. Both sides are using the pause to derisk: China pushing chip self-sufficiency, U.S. building rare-earth alternatives. Xi needs time for China’s economy (persistent slowdown); a high-level Communist Party meeting last week outlined a five-year growth strategy focused on state-directed manufacturing/tech investments. Trump gets dealmaker optics and soybean wins for GOP states. For Xi, a Washington state visit (not since Obama 2015) bolsters his global statesman image; a Trump Beijing visit would signal China weathered U.S. confrontation. Fundamental stress points (Taiwan, South China Sea, AI/quantum race) remain unresolved and volatile.

Why It Matters

The framework marks a pivotal shift from first-term confrontation to managed rivalry, signaling both sides recognize open conflict is too costly. For markets, the truce removes immediate tariff escalation risk (shelving new tariffs, rolling back 20% fentanyl levy), stabilizing trade-exposed sectors (agriculture, tech, manufacturing) and reducing recession fears. Resumed soybean purchases benefit U.S. farmers and GOP states, while delaying rare-earth controls eases supply-chain anxiety for tech/defense sectors reliant on Chinese minerals.

However, the truce is fragile and transactional—core issues (state subsidies, IP theft, tech dominance) remain unresolved, meaning structural risks persist. For China, the pause buys critical time to address domestic economic weakness (slowdown, deflation) and advance self-sufficiency in chips/tech, reducing U.S. leverage long-term. For the U.S., the detente allows focus on building rare-earth alternatives and derisking supply chains, but risks complacency if Beijing uses the window to leapfrog in AI/quantum. The structured diplomacy (Trump Beijing visit, Xi Washington visit) creates predictability but also vulnerability—one geopolitical provocation (Taiwan, South China Sea) or Trump social-media post could collapse the framework. For investors, the truce is a tactical relief rally catalyst but not a strategic all-clear; Taiwan, military tensions, and tech competition remain powder kegs.

What’s Next

Watch Thursday’s Trump-Xi summit in South Korea for deal details: soybean purchase volumes, rare-earth control timelines, tariff rollback specifics, and any surprises (tech, Taiwan, military). Monitor Trump’s Beijing visit timing (early 2026) and Xi’s Washington visit—delays or cancellations signal trouble. Track China’s five-year growth strategy execution: state-directed manufacturing/tech investments, chip self-sufficiency progress, and whether stimulus stabilizes the economy. For the U.S., watch rare-earth supply-chain diversification (MP Materials, Lynas partnerships) and whether Congress supports derisking initiatives.

Monitor Taiwan/South China Sea tensions—any flare-up could derail the truce. For markets, watch trade-exposed sectors (agriculture, tech, industrials) for relief rally sustainability. Risks: truce collapses over Taiwan/military incident, Trump reverses course, or China underdelivers on concessions. Catalysts: successful summits, major soybean/rare-earth deals, or economic stabilization in China. Favor U.S. agriculture (soybeans), rare-earth alternatives, and defensive plays; avoid overexposure to China-dependent supply chains until structural issues resolve.

Source
Previous Post

Trump Hails Golden Era in Japan Relations

Next Post

OpenAI’s Promise to Stay in California Helped Clear the Path for Its IPO

Recommended For You

Trump Cuts China Tariffs to Spur Fentanyl Crackdown and Trade De-escalation

by Team Lumida
1 hour ago
Trump Announces 25% Tariffs on Mexico and Canada, Targeting Border Security and Trade

Key Takeaways Powered by lumidawealth.com U.S. lowers select China tariffs tied to fentanyl to 10% from 20%, nudging average tariffs on most Chinese imports to ~45% from ~55%. China...

Read more

Fed Seen Cutting Rates, But With No Added Signal

by Team Lumida
1 day ago
Why Mortgage Servicers Are Thriving Amid High Rates

Key Takeaways Fed expected to cut rates 25 bps Wednesday (2 p.m. decision, Powell presser 30 min later); Chair Powell likely to offer little guidance as growing divide...

Read more

Trump Hails Golden Era in Japan Relations

by Team Lumida
1 day ago
Why Berkshire’s Latest Yen Bond Sale Could Ignite the Japanese Market

Key Takeaways Powered by lumidawealth.com Trump and new PM Takaichi pledged "golden age" of U.S.-Japan cooperation aboard USS George Washington; Takaichi vowed to boost defense spending to 2% of...

Read more

Rare Earths Producers Look to US-Led Boom to Blunt China’s Power

by Team Lumida
2 days ago
Rare Earths Producers Look to US-Led Boom to Blunt China’s Power

Key Takeaways Powered by lumidawealth.com US rare-earth magnet producers (Noveon, MP Materials) see surging demand after China's April export curbs; Adamas says US capacity could offset imports by 2028...

Read more

China Analysts Expect US to Ease Export Curbs for Magnet Relief

by Team Lumida
2 days ago
China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis

Key Takeaways Powered by lumidawealth.com Chinese analysts expect US to dial back Sept. 29 "affiliates rule" (restricting chip sales to subsidiaries of blacklisted Chinese firms like Huawei) in exchange...

Read more

China Expands Trade Pact With Asian Economies Courted by Trump

by Team Lumida
2 days ago
China’s Bold Economic Moves: What You Need to Know Now

Key Takeaways Powered by lumidawealth.com China and ASEAN signed upgraded free trade pact (CAFTA 3.0) Tuesday, adding green economy and supply-chain connectivity; helps China export solar/batteries/EVs and offset US...

Read more

Trump Adds 10% Tariff Threat Against Canada Amid Reagan Ad Dispute

by Team Lumida
3 days ago
flag of Canada

Key Takeaways Powered by lumidawealth.com Trump plans an additional 10% tariff on Canada in response to an Ontario ad using Ronald Reagan audio criticizing broad tariffs. Current U.S. tariffs...

Read more

China Industrial Profits Rebound Sharply on Low Base and Capacity Cuts

by Team Lumida
3 days ago
China’s Bold Economic Moves: What You Need to Know Now

Key Takeaways Powered by lumidawealth.com September industrial profits up 21.6% YoY, following 20.4% growth in August. Year-to-date profit growth improved to 3.2% vs 0.9% in January–August. 73.2% of surveyed...

Read more

US and China Begin Trade Talks in Malaysia to Ease Tensions

by Team Lumida
5 days ago
US Treasury Secretary Bessent: Terming Out US Debt Is “A Long Way Off”

Key Takeaways Powered by lumidawealth.com US Treasury Secretary Bessent and Chinese VP He Lifeng began talks Saturday in Kuala Lumpur to defuse trade standoff ahead of Trump-Xi summit Thursday...

Read more

China’s Grip on U.S. Drug Supply Emerges as a Geopolitical “Nuclear Option”

by Team Lumida
6 days ago
China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis

Key Takeaways: Powered by lumidawealth.com China controls much of the global supply of active pharmaceutical ingredients (APIs), vital to nearly 700 U.S. medicines. Beijing has not yet weaponized its...

Read more
Next Post
OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

OpenAI's Promise to Stay in California Helped Clear the Path for Its IPO

Booking Third-Quarter Sales Rise as U.S. Travel Demand Stabilizes

Booking Third-Quarter Sales Rise as U.S. Travel Demand Stabilizes

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

gold and silver round coin

Bitwise Files for Dogecoin ETF as Musk’s D.O.G.E Initiative Boosts Memecoin

January 23, 2025
a computer chip with the letter a on top of it

Nvidia’s Cutting-Edge Chips: The Future of Tech Innovation

August 30, 2024
gray industrial machine

Posco’s Profit Drops 43% as Trump Tariffs Hit Steel Production and Sales

April 24, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018